M. Aklilu

发表

The current landscape of locally advanced rectal cancer

C. Eng, M. Aklilu, 2011, Nature Reviews Clinical Oncology.

Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC)

H. Hurwitz, J. Bendell, G. Blobe, 2008 .

Microsatellite Instability and Outcomes in Colorectal Cancer

S. Nagalla, M. Aklilu, George Yacoub, 2012 .

Oncologic Management of Hereditary Colorectal Cancer

S. Nagalla, M. Aklilu, George Yacoub, 2012, Clinics in Colon and Rectal Surgery.

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC 1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

Anuradha, J. Marshall, D. Hsu, 2013 .

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

J. Marshall, D. Hsu, T. Crocenzi, 2013, Annals of surgery.

A Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma

J. Tepper, R. Goldberg, A. Ivanova, 2013, American journal of clinical oncology.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas

J. Lovato, Antonius A. Miller, M. Aklilu, 2012, BMC Cancer.

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma.

W. Stadler, N. Vogelzang, M. Mahowald, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma.

J. Marshall, M. Morse, D. Cole, 2006, Clinical colorectal cancer.

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery.

E. Shaw, J. Lovato, S. Tatter, 2012, Journal of neurosurgery.

A Phase II Trial of Weekly Intravenous Ranpirnase (Onconase®), a Novel Ribonuclease in Patients with Metastatic Kidney Cancer

W. Stadler, N. Vogelzang, M. Dumas, 2004, Investigational New Drugs.

Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

K. Geisinger, E. Levine, G. Riedlinger, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of flavopiridol in patients with advanced colorectal cancer.

E. Vokes, R. Donehower, S. Mani, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

T. Karrison, D. Geynisman, H. Kindler, 2013, Journal of Immunotherapy for Cancer.

A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot study.

B. Nicklas, N. Avis, S. Sohl, 2016, Complementary therapies in medicine.

Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer

P. Boddu, M. Aklilu, Dana Villlines, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Targeted agents and esophageal cancer--the next step?

D. Ilson, M. Aklilu, 2007, Seminars in Radiation Oncology.

Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer

S. Freels, A. Maker, G. Rauscher, 2016, Cancer.

A multi-center phase II study of arsenic trioxide (AT) in patients (Pts) with advanced pancreatic cancer (PC) refractory to gemcitabine

E. Vokes, H. Kindler, S. Nattam, 2004 .

A multi-center phase II study of arsenic trioxide (AT) in patients (Pts) with advanced pancreatic cancer (PC) refractory to gemcitabine.

E. Vokes, H. Kindler, S. Nattam, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.

H. Hurwitz, J. Bendell, G. Blobe, 2011, Anticancer research.

A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease

F. Torti, M. Dimairo, A. Hussain, 2011 .

Arsenic Trioxide in Patients With Adenocarcinoma of the Pancreas Refractory to Gemcitabine: A Phase II Trial of the University of Chicago Phase II Consortium

E. Vokes, H. Kindler, S. Nattam, 2008, American journal of clinical oncology.

Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.

J. Marshall, T. Crocenzi, D. Niedzwiecki, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Questions without answers.

F. Torti, M. Aklilu, 2005, Current opinion in oncology.

Optimal Timing of Systemic Therapy in Resectable Colorectal Liver Metastases

E. Levine, P. Shen, C. Ihemelandu, 2013, The American surgeon.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas

J. Lovato, Antonius A. Miller, M. Aklilu, 2012, BMC Cancer.

A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.

J. Marshall, T. Crocenzi, D. Niedzwiecki, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorectal/Appendiceal Cancer

T. McCoy, E. Levine, P. Shen, 2014, Journal of Gastrointestinal Cancer.